Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Head and neck synovial cell sarcoma.

F R Amble1, K D Olsen, A G Nascimento

  • 1Department of Otolaryngology, Mayo Clinic, Rochester, MN 55905.

Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|November 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exposure to Anti-TNF Medications Does Not Increase the Risk of Cardiac Arrhythmia in Inflammatory Bowel Disease: A Population-Based Cohort Study.

Gastro hep advances·2024
Same author

Corrigendum to "SELNET clinical practice guidelines for soft tissue sarcoma and GIST" [Cancer Treat. Rev. 102 (2021) 102312].

Cancer treatment reviews·2023
Same author

30-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-escalation trials (MC1273 & MC1675).

Oral oncology·2023
Same author

Corrigendum to "SELNET clinical practice guidelines for bone sarcoma" Critical reviews in oncology/hematology, vol. 174 (2022), 1-10.

Critical reviews in oncology/hematology·2022
Same author

Scalable radiotherapy data curation infrastructure for deep-learning based autosegmentation of organs-at-risk: A case study in head and neck cancer.

Frontiers in oncology·2022
Same author

SELNET clinical practice guidelines for bone sarcoma.

Critical reviews in oncology/hematology·2022

Synovial cell sarcoma, a rare cancer in young adults, often presents as a neck mass and can be misdiagnosed. Early detection and wide surgical removal improve patient prognosis.

Area of Science:

  • Oncology
  • Pathology
  • Surgical Oncology

Background:

  • Synovial cell sarcoma is a rare malignancy affecting young individuals.
  • Diagnosis can be challenging, with a significant rate of initial mispathologizing.
  • A painless neck mass is the most frequent initial clinical presentation.

Observation:

  • This study reviewed 14 patients diagnosed with synovial cell sarcoma over 30 years.
  • Patient ages ranged from 12 to 43 years.
  • One-third of patients initially received incorrect pathological diagnoses.

Findings:

  • Painless neck mass was the most common presenting symptom.
  • Treatment involved surgical excision alone or combined with radiation therapy.
  • Recurrence or metastasis occurred between 4 and 62 months post-initial treatment.

Related Experiment Videos

  • Long-term follow-up is crucial, as 4 of 9 patients followed over 5 years succumbed to the disease.
  • Favorable prognostic indicators included early diagnosis and wide surgical excision.
  • Implications:

    • Highlights the diagnostic challenges and the need for accurate pathological assessment.
    • Emphasizes the importance of long-term patient monitoring for recurrence or metastasis.
    • Underscores the benefit of prompt diagnosis and aggressive surgical management in improving outcomes for synovial cell sarcoma.